ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,831 Cr | ₹-1,198 Cr | ₹-1,068 Cr | ₹-942 Cr | ₹-955 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1,831 Cr |
| Mar2024 | ₹-1,198 Cr |
| Mar2023 | ₹-1,068 Cr |
| Mar2022 | ₹-942 Cr |
| Mar2021 | ₹-955 Cr |
How is Deferred Tax Assets / Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,831 Cr | Negative | |
| Mar2024 | ₹-1,198 Cr | Negative | |
| Mar2023 | ₹-1,068 Cr | Negative | |
| Mar2022 | ₹-942 Cr | Negative | |
| Mar2021 | ₹-955 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹91,715.1 Cr | 0.4% | -1.1% | -4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 0.4% |
-1.1% |
-4.7% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses